Catron; Nathaniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Catron; Nathaniel.The latest application filed is for "solid dispersions containing an apoptosis-inducing agent".

Company Profile

7.10.15

Catron; Nathaniel - Vernon Hills IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid Dispersions Containing An Apoptosis-inducing Agent App 20220125796 - Catron; Nathaniel ; et al.	2022-04-28
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20200361932 - Catron; Nathaniel ; et al.	2020-11-19
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20200255425 - Kind Code	2020-08-13
Salts and crystalline forms of an apoptosis-inducing agent Grant 10,730,873 - Catron , et al.	2020-08-04
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20200231593 - Catron; Nathaniel ; et al.	2020-07-23
Solid Dispersions Containing An Apoptosis-inducing Agent App 20190275051 - Catron; Nathaniel ; et al.	2019-09-12
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20190194196 - Catron; Nathaniel ; et al.	2019-06-27
Solid dispersions containing an apoptosis-inducing agent Grant 10,213,433 - Catron , et al. Feb	2019-02-26
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20180065961 - Catron; Nathaniel ; et al.	2018-03-08
Salts and crystalline forms of an apoptosis-inducing agent Grant 9,840,502 - Catron , et al. December 12, 2	2017-12-12
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20160083384 - Catron; Nathaniel ; et al.	2016-03-24
Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phen- yl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide Grant 9,238,649 - Catron , et al. January 19, 2	2016-01-19
Solid Dispersions Containing An Apoptosis-inducing Agent App 20150157639 - Catron; Nathaniel ; et al.	2015-06-11
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20140213596 - Catron; Nathaniel ; et al.	2014-07-31
Stabilized lipid formulation of apoptosis promoter Grant 8,728,516 - Catron , et al. May 20, 2	2014-05-20
Salts and crystalline forms of an apoptosis-inducing agent Grant 8,722,657 - Catron , et al. May 13, 2	2014-05-13
Salt of ABT-263 and solid-state forms thereof Grant 8,362,013 - Borchardt , et al. January 29, 2	2013-01-29
Solid Dispersions Containing An Apoptosis-inducing Agent App 20120277210 - Catron; Nathaniel ; et al.	2012-11-01
Salts And Crystalline Forms Of An Apoptosis-inducing Agent App 20120157470 - Catron; Nathaniel ; et al.	2012-06-21
Salt Of Abt-263 And Solid-state Forms Thereof App 20100305125 - Borchardt; Thomas ; et al.	2010-12-02
Formulation For Oral Administration Of Apoptosis Promoter App 20100297194 - Catron; Nathaniel ; et al.	2010-11-25
Stabilized Lipid Formulation Of Apoptosis Promoter App 20100278905 - Catron; Nathaniel ; et al.	2010-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.